For use later - bb if you read this yes its for you.
SUBJECT: Re:FDA Posted By: Beckysboss
Post Time: 6/25/02 19:27
« Previous Message Next Message »
Officials at Bristol-Myers knew that ImClone was deceiving investors. One internal e-mail released
by congressional investigators reads, “I agree that some alot [sic] of Sam’s comments are
misleading.” And I’ll bet many of the staffers at the FDA knew, too.
By law and by regulation, there wasn’t much the FDA could do about that. It is prohibited from
making information about a drug application public. And by law it can’t even exchange information
about the applications with other federal agencies. In other words, the FDA couldn’t even alert the
SEC about a potential problem at ImClone.
Barcelo,
I hope a few of the resident pumpers took the time to read through the article you posted. Fact is there is very little difference in the delays by HC and FDA when it comes to Pennsaid, except for one fact. HC will make public non-conformance issues, while the FDA keeps it between the company and themselves. This allows a CEO to spin delays any way they feel like it.
A CEO can choose to tell shareholders pretty much whatever he/she wants knowing full well the FDA will not disclose anything publicly (unless dragged into it by Congress). So its easy on the surface to declare 'ongoing discussions' and assure approvals while feverishly working on clinical trials in the background. Except once in a while HC throws a ringer out. Talk about controlling the agenda. Thats the problem with the 'forward looking' statement clause, it gives CEOs almost free reign on what you hear.
Believe what you want folks , believe the pumpers , IMHO the trials going on now are for approvals and nothing will happen until there done, the statistics are pulled together and the FDA has a boo at the results. Get used to Acqua , there not going anywhere. Trials cost money and Becky needs them, her 'friends' on Bay St. aren't buying. If Becky told you the scuttlebut this stock would be in the pennies, great motivation to keep it to insiders.
By the way at the UBS/Warburg conference (where J&J were not mentioned ) Becky said she hoped to hear from the FDA in August. Nothing about approvals. Listen close, theres a message there. |
